Preliminary experiments reveal conolidine may well inhibit unique ion channels, lessening neuronal excitability and limiting discomfort signals. This system is particularly applicable in neuropathic agony, in which abnormal signaling results in persistent discomfort. On top of that, conolidine appears to influence G protein-coupled receptor (GPCR) pathways integral to discomfort https://davide035lif6.wikitidings.com/user